Use of docetaxel (Taxotere®) in patients with paclitaxel (Taxol®) hypersensitivity

Anti-Cancer Drugs

Volumn 11, Issue 7, 2000, Pages 565-568

  Moon, Chulso ^a   Verschraegen, Claire F ^a   Bevers, Michael ^a   Freedman, Ralph ^a   Kudelka, Andrzej P ^a   Kavanagh, John J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Allergic reactions; Ovarian neoplasms; Taxane

Indexed keywords

CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; PACLITAXEL; TOPOTECAN; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; TAXOID;

ADULT; ANAPHYLAXIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CASE REPORT; DRUG CHOICE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RISK ASSESSMENT; CARCINOMA; CYSTADENOCARCINOMA; DRUG ADMINISTRATION; DRUG COMBINATION; MIDDLE AGED; OVARY TUMOR;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; CIMETIDINE; CYSTADENOCARCINOMA; DEXAMETHASONE; DIPHENHYDRAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL; TAXOIDS;

EID: 0033626593     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200008000-00007     Document Type: Article

References (15)

1. Current status of clinical trials with paclitaxel and docetaxel
2. Case report of anaphylaxis from cisplatin/paclitaxel and a review of their hypersensitivity reaction profiles
3. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion
4. Hypersensitivity reactions from taxol
5. Paclitaxel (Taxol)
6. Clinical toxicities encountered with paclitaxel (Taxol)
7. Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions
8. Suspected anaphylactic reaction to Cremophor EL
9. VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children
10. Paclitaxel hypersensitivity revisited
11. Effective desensitization protocol to paclitaxel following hypersensitivity reaction
12. Paclitaxel (Taxol) and docetaxel (Taxotere): Not simply two of a kind
13. Paclitaxel hypersensitivity reactions: A role for docetaxel substitution
14. Paclitaxel rechallenge failure after a major hypersensitivity reaction
15. Docetaxel